Daily Stock Analysis, FLXN, Flexion Therapeutics Inc, priceseries

Flexion Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
14.40
Close
14.21
High
14.64
Low
14.14
Previous Close
14.44
Daily Price Gain
-0.23
YTD High
15.16
YTD High Date
Jan 31, 2019
YTD Low
10.98
YTD Low Date
Jan 4, 2019
YTD Price Change
1.75
YTD Gain
14.04%
52 Week High
29.10
52 Week High Date
Jun 20, 2018
52 Week Low
10.98
52 Week Low Date
Jan 4, 2019
52 Week Price Change
-9.98
52 Week Gain
-41.26%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 19. 2017
17.79
Jul 31. 2017
23.29
29 Trading Days
30.91%
Link
LONG
Aug 22. 2017
22.89
Sep 1. 2017
24.26
8 Trading Days
5.97%
Link
Company Information
Stock Symbol
FLXN
Exchange
NasdaqGM
Company URL
http://www.flexiontherapeutics.com
Company Phone
(781) 305-7777
CEO
Michael D. Clayman
Headquarters
Massachusetts
Business Address
10 MALL ROAD, SUITE 301, BURLINGTON, MA 01803
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001419600
About

Flexion Therapeutics, Inc. is a pharmaceutical company focuses on development and commercialization of novel, local therapies. It specializes in treatment of patients with musculoskeletal conditions including osteoarthritis, a type of degenerative arthritis. Its products include Zilretta. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.

Description

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.